Lumbar degenerative spondylolisthesis (DS) is a common cause of low back pain, radiculopathy, and/or neurogenic claudication. Treatment begins with a trial of nonsurgical methods, including physical therapy, NSAIDs, and epidural corticosteroid injections. Surgical treatment with decompression and fusion is recommended for patients who do not respond to this initial regimen. Although much has been published in the past two decades on the surgical management of DS, the optimal method remains controversial. Interbody fusion may improve arthrodesis rates and can be performed via numerous surgical approaches. Minimally invasive techniques continue to be developed. Particular attention to surgical management of DS in the elderly is warranted given the increasing numbers of elderly persons. Healthcare utilization in the future must take into account evidence-based medicine that establishes clinically effective practices while simultaneously being cost effective.
S
pondylolisthesis is the subluxation of one vertebra relative to an adjacent vertebra. Lumbar degenerative spondylolisthesis (DS) is an acquired type and is a frequent cause of spinal stenosis. Clinicians should have a thorough understanding of all management options in order to treat each patient in a manner that is both clinically and cost-effective.
Surgical Management
Surgical treatment should be considered for patients whose symptoms are debilitating and recalcitrant to nonsurgical management. 1 Surgery is most appropriate for radicular pain and/or neurogenic claudication that limits the time a patient can stand and/or the distance she or he can walk. Patients who present with bowel or bladder dysfunction or with progressive weakness should undergo surgical treatment on a more urgent basis. Most patients can expect to be satisfied with their surgical treatment results. One study reported a satisfaction rate of 86.6%. 2 Although the number of surgical options available to manage DS has increased in the past decade, decompression laminectomy with partial medial facetectomy and instrumented fusion remains the standard against which all other novel techniques must be compared.
Decompression Without Fusion
The foundation of surgical management of DS involves decompression of the associated spinal stenosis. Laminectomy is the most common method of decompression. This procedure Dr. Eismont or an immediate family member has received royalties from, is a member of a speakers' bureau or has made paid presentations on behalf of, serves as a paid consultant to, and has stock or stock options held in Alphatec Spine. Dr. Norton or an immediate family member has stock or stock options held in InVivo Therapeutics. Neither Dr. Hirsch nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article.
J Am Acad Orthop Surg 2014; 22: 203-213 allows for direct decompression of the central canal, lateral recess, and neural foramen. Laminotomy is an alternative approach to decompression in which the vertebral arch is preserved.
The use of decompression to manage DS is supported by several early studies that relied on qualitative outcome data. In 1994, Mardjetko et al 3 published a meta-analysis of 11 studies and reported that 69% of patients had a satisfactory outcome with decompression alone. Subsequent series published by Epstein 4 and by Kristof et al 5 found similar rates of good to excellent outcomes in older patients without dynamic instability on lateral radiographs who were treated with decompression alone (82% and 73.5%, respectively).
Although decompression and fusion has become the most common surgical technique for the management of DS, 6 several recent studies have generated renewed interest in using decompression alone in select patient populations. 7, 8 Advocates of decompression alone contend that elderly patients with so-called stable DS may be better served by the lower morbidity and mortality associated with that approach.
Decompression With Noninstrumented Fusion
Currently, most patients with DS are treated with lumbar fusion and neural decompression. Laminectomy and fusion was shown to be superior to laminectomy alone in a landmark prospective, randomized study of 50 patients published in 1991 by Herkowitz and Kurz. 9 Patients treated with laminectomy and arthrodesis had significantly less leg and back pain (P , 0.01) and a significantly higher proportion of good to excellent overall clinical results (P = 0.0001) than did patients who underwent laminectomy alone. Noninstrumented posterolateral fusion (PLF) was performed using autogenous iliac crest bone graft. Average follow-up was 3 years. Of note, pseudarthrosis, which occurred in 36% of the fusion cases, did not appear to affect the clinical outcome within the time frame of this study. In a more recent systematic review, Martin et al 10 confirmed the beneficial role of noninstrumented fusion in managing DS.
Decompression With Instrumented Posterolateral Fusion
The use of posterior instrumentation in conjunction with fusion for DS has been shown to reduce the risk of pseudarthrosis; however, its effect on clinical outcomes remains unclear ( Figure 1 ). In a classic study, Fischgrund et al 11 randomized 76 patients with DS to either instrumented or noninstrumented single-level decompression and fusion. At a minimum follow-up of 2 years, patients with instrumented fusion had a significantly higher fusion rate (82% and 45%, respectively), but there was no statistically significant difference in clinical outcomes. In a follow-up study of 47 of these patients (average follow-up, 7 years, 8 months), patients with a solid fusion had significantly better clinical outcomes than did patients with pseudarthrosis (P = 0.01). 12 The authors concluded that successful fusion has clinical benefit at long-term follow-up and that instrumented fusion should be considered in patients at risk for pseudarthrosis.
No definitive relationship between instrumentation and enhanced patient outcomes has been demonstrated in a high-quality long-term study. However, given the abundance of data demonstrating improved fusion rates with the use of instrumentation, instrumented fusion has become the standard of care.
Degenerative Spondylolisthesis and the SPORT Perspective
The Spine Patient Outcomes Research Trial (SPORT) was a prospective, multicenter trial with a randomized cohort and concurrent observational cohort that compared surgical with nonsurgical treatment of patients with symptomatic DS. 13 The randomized cohort consisted of 304 patients, with 303 patients enrolled in the observational cohort. To date, this is the largest study of patients with DS, and it should be considered the standard against which all future studies should be measured. Surgery consisted of posterior decompressive laminectomy with or without single-level fusion performed with or without instrumentation. The nonsurgical protocol consisted of the usual clinical care. The authors attempted to use an intent-to-treat analysis; however, a significant amount of crossover occurred, with only 64% of patients assigned to surgery and 49% of patients assigned to nonsurgical management ultimately undergoing surgery within 2 years following enrollment. These high rates of crossover precluded any useful interpretation of data generated by the intent-to-treat analysis. The astreated analysis, however, which combined both the observational and randomized cohorts while adjusting for potential confounders, demonstrated substantially greater improvement in pain and function in the surgical group at 2-year followup. This improvement was maintained at 4-year follow-up, at which time patients treated surgically experienced a mean decrease in Oswestry Disability Index (ODI) score of 23, compared with a mean decrease of 8.6 in the nonsurgical group, for a treatment effect of 14.3 (P , 0.001). 2 The Medical Outcomes Study 36-Item Short Form physical function score improved by 26.6 in the surgical group, compared with only 7.7 in the nonsurgical group, for a treatment effect of 18.9 (P , 0.001). Additionally, 67.1% of patients treated surgically reported a major improvement in symptoms, compared with only 21% of the nonsurgically treated patients. In patients who undergo surgery for DS, the minimum clinically important difference in ODI score has been shown to be 14.9. 14 Further examination of the SPORT data demonstrated that although patients with DS and spinal stenosis have similar characteristics, surgical treatment results in greater improvement in patients with DS than in patients with spinal stenosis. 15 Another post hoc analysis determined that patients with predominant leg pain improved significantly more with surgery than did patients with predominant low back pain. 16 Researchers also found that regardless of listhesis grade, disk height, or intervertebral mobility, surgically treated patients improved more than did nonsurgically treated patients. 17 Further subgroup analyses of 380 patients with DS showed that 80 had posterolateral in situ fusion, 213 had posterolateral instrumented fusion, 63 had 360°fusion, and 23 had decompression alone without fusion. 18 At 4-year follow-up, no consistent difference in clinical outcomes was found between these fusion methods. In addition, the type of bone graft used (ie, posterior iliac crest bone graft, local bone graft, morcellized allograft, bone graft substitute) made no difference in clinical outcome measures over 4 years. Moreover, in their subgroup analysis of patients treated with posterior iliac crest bone graft, Radcliff et al 19 determined that although iliac crest bone graft was associated with longer surgical time and greater blood loss, it was not associated with increased complication or reoperation rates, and they further determined that clinical success was equivalent to that following fusion without iliac crest autograft in the setting of DS.
The SPORT data also were used to evaluate patients with DS in the setting of multilevel stenosis. Park et al 20 found that patients with DS and single-level stenosis do better surgically than their counterparts with multilevel stenosis. Smorgick et al 21 compared the results of multilevel decompression and single-level fusion with multilevel decompression and fusion in patients with singlelevel DS associated with multilevel stenosis. Although outcomes were similar with both procedures, multilevel fusion was associated with significantly longer surgical time and greater blood loss. 
Interbody Fusion
The addition of an interbody fusion in the context of DS has been an additional source of debate. Theoretically, it increases the surface area for fusion and improves the initial stability of a construct. In 2009, the North American Spine Society clinical guidelines posed the question as to whether 360°fusion improves outcome measures compared with decompression and PLF alone. 1 They found few studies addressing this question, however, and were unable to make a recommendation. Since then, several studies have addressed this topic.
Interbody fusion can be performed via various surgical approaches, each with its own advantages and disadvantages. Of all the interbody fusion approaches, anterior lumbar interbody fusion (ALIF) has the longest history of use, yet few studies have specifically focused on ALIF in the management of DS. Advantages include indirect nerve root decompression, restoration of disk height and sagittal alignment, reduction of anterolisthesis, and a large footprint for graft insertion ( Figure 2 ). Disadvantages include all the morbidities associated with an anterior approach to the lumbar spine. Satomi et al 22 compared ALIF with posterior decompression in 27 patients and reported improvement in Japanese Orthopaedic Association (JOA) outcome scores in 77% who underwent ALIF and 56% who underwent posterior decompression. Excellent improvement in JOA score was noted in 56% of patients treated with ALIF and in 36% of patients treated with posterior decompression. Similarly, Takahashi et al 23 found that 76% of patients treated with ALIF to manage DS had a satisfactory clinical result at 10-year follow-up as measured by the JOA score. Kanamori et al 24 retrospectively reviewed 20 patients who underwent ALIF to manage DS. At a minimum follow-up of 10 years, the rate of bony union in the grafted area was 100%. However, six patients (30%) had clinical deterioration secondary to adjacent segment disease (ASD) requiring surgical intervention. Posterior lumbar interbody fusion (PLIF) (Figure 3 ) and transforaminal lumbar interbody fusion (TLIF) both avoid the morbidity associated with an anterior approach and the time required for two surgical approaches by allowing access to the disk space via a posterior approach. TLIF has the added benefit of easier access to the neuroforamen and disk space with less manipulation of the neural elements. Furthermore, TLIF can be performed unilaterally with less disruption of the posterior elements. TLIF and PLIF have been shown to be safe and effective in the surgical management of DS. 25, 26 In a retrospective study comparing PLIF and TLIF, both techniques were shown to provide significant clinical improvement. 27 The JOA functional disability score was 84.1% good or excellent in all patients (83.5% with PLIF, 84.6% with TLIF). Improvement in visual analog scale (VAS) pain score was also significant for both groups (P , 0.001). Both techniques also provided significant radiographic improvement based on percent slip reduction, gain in intervertebral disk height, and improvement in foraminal height (P , 0.05 for each). At 2-year follow-up, TLIF was determined to be safer than PLIF and easier to perform.
Ha et al 28 retrospectively compared decompression and PLF with and without the addition of a PLIF to manage symptomatic DS at L4-5 in 40 patients. Stability was defined as ,4 mm of slip and/or a slip angle of ,10°on preoperative dynamic flexion-extension radiographs. At 2-year follow-up, there was no significant difference in ODI and VAS scores with the addition of PLIF in patients with stable DS; however, in patients with unstable DS, clinical outcomes were significantly improved with the addition of an interbody fusion. Reduction in ODI score was 22% 6 16.1% in the PLF group compared with 42.3% 6 17.9% in the PLF plus PLIF group (P = 0.03). Reduction in VAS was 2.6 6 1.9 in the PLF group and 5.9 6 1.8 in the PLF plus PLIF group (P = 0.004). Furthermore, the degree of disk height restoration directly correlated with improved clinical outcome. This study suggests that identification of preoperative instability may aid in determining whether an interbody fusion is warranted.
Lateral (ie, transpsoas) interbody fusion was introduced in 2006 as a less invasive alternative to conventional anterior and posterior approaches to interbody fusion 29 ( Figure 4 ). This approach has the advantage of reduced risk of neural complications and posterior element disruption compared with a posterior approach. The lateral approach also reduces the risks of vascular and visceral injury associated with an anterior approach. 29 However, with this approach it is more difficult to manage these injuries should they occur. Additionally, there is an increased risk of injury to the lumbar plexus during dissection through the psoas muscle, with the potential to cause postoperative thigh pain or dysesthesias and quadriceps weakness, which is transient in most cases. In a review of 235 patients, Pumberger et al 30 described sensory deficits in 28.7% at 6 weeks, which improved to 1.6% at 12 months; anterior groin/thigh pain in 41% at 6 weeks, which improved to 0.8% at 12 months; and motor deficits in 4.9% at 6 weeks, which improved to 2.9% at 12 months.
Marchi et al 31 recently published their prospective nonrandomized observational study on 52 consecutive patients treated with stand-alone lateral interbody fusion to manage low-grade DS. The fusion rate was 86.5%, the ODI score improved 54.5%, the VAS score improved 60%, and mean listhesis was reduced from 15.1% to 7.1% at a minimum follow-up of 24 months (P , 0.001). However, cage subsidence occurred in 17% of patients, and pseudarthrosis was found in 13.5%. Overall, revision surgery was required in 13% of cases secondary to subsidence with instability/recurrent stenosis or due to inadequate indirect decompression.
Lateral interbody fusion appears to have short-term clinical and radiographic success comparable to that of traditional anterior or posterior procedures but with the added benefit of minimal invasiveness.
Intermediate and long-term studies are lacking, however.
Degenerative listhesis rarely exceeds Meyerding grade I or II due to the inherent stability that occurs with disease progression. When instrumentation is indicated, posterior-only constructs appear to be sufficient for most cases of DS. This concept is supported by the SPORT subgroup analysis of differing fusion techniques, which indicates no clear advantage of one fusion technique over any other. 18 However, the addition of interbody fusion should be considered in patients who are at high risk of nonunion and in the presence of local kyphosis, high-grade slip, symptomatic instability with sagittally oriented facet joints, joint effusion on MRI, and a tall intervertebral disk.
Regardless of surgical approach, the goals of interbody fusion are to stabilize the anterior column, enhance the fusion rate, and improve sagittal alignment and disk height. 32 A secondary benefit of interbody fusion is that it allows for indirect decompression in the setting of foraminal stenosis. Pedicle screw fixation alone is biomechanically adequate when anterior load-sharing is preserved; however, in the setting of an insufficient anterior column (eg, grade II slip or greater, excessive motion on dynamic radiographs), pedicle screws alone may not provide adequate stability. In such cases, the addition of an interbody cage may improve construct stiffness. 33 
Minimally Invasive Decompression
Recent studies have shown that with the aid of a microscope and tubular retractors, minimally invasive (MIS) procedures to decompress the spinal canal are as effective as open laminectomy. 34, 35 MIS decompression techniques continue to evolve, and although they demonstrate shortterm potential, long-term follow-up A, Lateral radiograph demonstrating L4-5 degenerative spondylolisthesis in an 81-year-old woman who presented with bilateral leg pain so severe that she could walk no more than 1 block. Sagittal (B) and axial (C) T2-weighted magnetic resonance images demonstrating the severe degree of stenosis associated with this degenerative spondylolisthesis. D, Lateral radiograph 4 months following lateral transpsoas interbody fusion with posterior percutaneous screw fixation at L4-5 demonstrating good position of the bone graft. Although the patient reported transient thigh numbness on the approach side lasting for 2 months postoperatively, at 4-month follow-up she had neither back nor leg pain.
is needed to determine whether outcomes deteriorate, as was the case with traditional open laminectomy techniques for treating patients with DS.
Jang et al 7 retrospectively reviewed 21 patients who underwent MIS lumbar laminoplasty (ie, microsurgical bilateral decompression via a unilateral approach) for lumbar stenosis with associated grade I DS. At a minimum follow-up of 3 years, the ODI score improved from 59.52 to 26.19 even though postoperative slippage occurred in 10 of 22 levels at a minimum follow-up of 18 months. The increase in slippage was significantly greater in patients with preoperative evidence of sagittal motion on dynamic radiographs, which indicates that decompression without concomitant fusion should be reserved for the patient with a stable DS with minimal sagittal motion and primarily radicular symptoms.
Kelleher et al 36 retrospectively reviewed prospectively collected outcomes data on 25 patients with grade I DS who reported leg-dominant symptoms with no significant back pain and no obvious dynamic instability. Surgical intervention consisted of decompression alone via MIS lumbar laminoplasty. The ODI score improved from 48 to 24.6 (P , 0.001) and overall, 77.8% of patients were satisfied with their treatment at a mean follow-up of 31.8 months. Mean slip progression was 8.4% in nine patients, and new slip occurred in two patients. The degree of listhesis or radiographic slip progression did not correlate with the need for revision. Improvement in ODI scores, revision rates, and durotomy rate all compared favorably to those of the SPORT studies. Using a cost-benefit analysis, the authors determined an approximate cost savings to the hospital system of $8,330 Canadian when doing same-day MIS decompression surgery compared with a 5-day length of stay for a traditional decompression and single-level fusion.
Minimally Invasive Decompression and Fusion
Wang et al 37 prospectively studied 85 patients with degenerative and isthmic spondylolisthesis who were randomly assigned to either MIS-TLIF or open TLIF. Surgical time, ODI score, and back pain VAS score were equivalent between the two groups at a mean follow-up of 26.3 months. Patients treated with MIS-TLIF had the added benefit of less total blood loss (P , 0.01), a lower postoperative back pain VAS score (P , 0.05), and shorter hospital length of stay (P , 0.05). Patients treated with MIS-TLIF had greater X-ray exposure (P , 0.05).
Kim et al 38 reported the clinical and radiographic outcomes of MIS-TLIF with percutaneous pedicle screw fixation in 44 patients, 19 of whom presented with DS and 25 of whom presented with isthmic spondylolisthesis. Significant improvement was found in ODI score and in the VAS back and leg scores (P , 0.001). These findings were maintained at a minimum 5-year follow-up. The overall patient satisfaction rate was 80%. CT and/or dynamic radiography demonstrated fusion in all patients with DS. Radiographic ASD was found in 13 patients (68.4%), and symptomatic ASD was found in only 3 patients (15.8%). The authors determined MIS-TLIF to be a safe and effective surgical technique at 5-year follow-up.
Dynamic Stabilization
Dynamic stabilization was developed as a motion-preserving technique with the goal of overcoming the pitfalls of fusion while providing stability and potentially avoiding ASD.
Schaeren et al 39 prospectively studied the role of dynamic stabilization in the management of singlelevel DS. Nineteen of the 26 patients in their study were followed for at least 4 years. Leg pain as determined on the VAS scale improved significantly, as did walking distance (P , 0.001). Eighty-four percent of patients had no more claudication. Radiographically, spondylolisthesis did not progress, and the motion segments remained stable. Implant failure occurred in four patients (21%); of these, three had asymptomatic screw loosening and one experienced obvious screw loosening and breakage. Forty-seven percent of patients developed new signs of ASD. Overall patient satisfaction remained high, with 79% of patients reporting they would definitely undergo the same procedure again and 16% reporting that they would probably undergo the same procedure again. The authors concluded that decompression and dynamic stabilization could maintain clinical improvement and radiologic stability over 4 years, making it an alternative to fusion. In this series, however, dynamic stabilization did not prevent the development of ASD.
Similar clinical and radiographic results were found at a mean follow-up of 7.2 years in a retrospective analysis of 39 patients. 40 At final follow-up, 89% of the patients reported improved back pain and 86% reported improved leg pain according to the Grob questionnaire. Ninety-two percent indicated they would undergo the same procedure again. Mild radiographic progression of degeneration was observed in 9 patients, and radiologic signs of ASD were observed in 18, although without clinical correlation. Eight patients required reoperation-six due to symptomatic ASD, one due to late-onset infection, and one due to screw breakage. Seventy-three percent of instrumented segments became functionally fused, prompting the authors to hypothesize that over time this dynamic stabilization system works as a fusion device. Thus, clinically favorable results likely were not due to the potential motion-preserving intention of the device.
Lumbar Interspinous Spacers
Several FDA-approved interspinous devices (ISDs) are currently available for use ( Figure 5 ). Although these devices vary in design and composition, they have the common goal of distracting between adjacent spinous processes, thereby increasing the diameter of the spinal canal and blocking segmental extension.
In 2010, Kabir et al 41 performed a systematic review of the existing clinical and biomechanical research on these devices. Although they found current biomechanical evidence to support the notion of a potential beneficial effect of ISDs on the kinematics of the degenerative spine, clinical studies are not as conclusive.
Anderson et al 42 conducted a prospective, randomized trial involving 75 patients with neurogenic claudication and grade I DS. Forty-two patients underwent implantation of the X-STOP device (Medtronic), and 33 patients were treated nonsurgically. Significant improvements were observed in the Zurich Claudication Questionnaire score, patient satisfaction, and the Medical Outcomes Study 36-Item Short Form outcome measures in the ISD group but not in the control group. The overall clinical success rate was 63.4% in the implant group and 12.9% in the nonsurgical group at 2-year follow-up. Comparative studies of this implant and other standard surgical interventions are lacking.
Lumbar ISD may be beneficial in a select group of patients. However, more high-quality studies are needed to fully elucidate the proper indications for the use of ISDs and the long-term outcomes of such devices.
Degenerative Spondylolisthesis and the Elderly
As life expectancy continues to increase and the size of the elderly population continues to grow, so too does the number of elderly patients presenting to spine surgeons with disabling degenerative conditions of the spine. In general, elderly patients have been considered to be at high risk for complications secondary to their age-related comorbidities. The two primary concerns with this patient population are pseudarthrosis and hardware failure or loosening secondary to poor bone quality, and an increased number and severity of comorbidities with resultant higher rates of perioperative morbidity.
Rodgers et al 43 found complication rates, blood loss/transfusion rate, and hospital stay to be significantly lower following MIS transpsoas interbody fusion than following open PLIF in octogenarians (P , 0.0001). Other studies have substantiated these findings. In a study of elderly patients, Lee et al 44 found MIS-TLIF to yield significant improvements in VAS and ODI scores (P , 0.001) and reported overall clinical success in 88.9% of patients with a low rate of complications (7.4%) at a minimum follow-up of 36 months. The pseudarthrosis rate was 22.2%, and ASD occurred in 44.4% of patients. However, there were no reoperations, and clinical outcome measures were successful in all patients without a solid fusion. It should be noted that satisfactory clinical and radiographic success with relatively low complication rates has been reported in elderly patients treated with traditional decompression and instrumented PLF. 45 Age alone should not be a contraindication to surgical intervention. Well-indicated elderly patients treated with preoperative optimization and close perioperative medical management can expect successful outcomes.
Cost-effectiveness and Cost-utility Analysis of DS Management
Physicians must have an awareness of the cost-effectiveness of intervention in terms of improved patient quality of life and the economic impact on society as a whole. Costeffectiveness analysis compares the effectiveness of two or more interventions to calculate the cost-benefit ratio. Treatment effectiveness is measured using quality-adjusted life years (QALYs) and takes into account both quality and length of life as measured by standardized outcome tools, most often the EuroQol Five Dimension form. The cost of an intervention should take into account both direct costs (ie, resource utilization, cost of medical care) and indirect costs (ie, productivity loss). The incremental costeffectiveness ratio is then calculated as the difference in incurred costs divided by the difference in accrued QALYs between two treatment groups. No definitive cost-effectiveness threshold has been defined in the United States; however, when the incremental cost-effectiveness ratio is ,$50,000 per QALY, the intervention is generally considered to be cost-effective. 46 In cost-utility analysis, QALYs are calculated by applying different utility weightsranging from 0 (death) to 1 (full health)-to life expectancy in relation to level of health experienced over time.
With increased interest in costefficient medicine and increased scrutiny of the economic value of spine surgery, more is being published in an effort to justify or repudiate surgical interventions. A recent subanalysis of the SPORT data determined that surgical management of DS was not highly costeffective at 2-year follow-up but was cost-effective at 4-year follow-up. 47 There was no difference in costeffectiveness between fusion types. In an analysis of 45 patients who underwent TLIF for DS, Adogwa et al 48 reported a cost per QALY of $42,854 at 2-year follow-up, which compares favorably with other wellaccepted cost-effective treatments such as total hip arthroplasty and total knee arthroplasty. They emphasize the difficulty in determining the true utility (ie, QALYs gained) in a surgical group secondary to variation in patient selection as well as the potential inflation of QALYs gained in a medical cohort.
Given the renewed interest in MIS decompression alone, Kim et al 49 sought to establish whether there is any cost savings with MIS decompression techniques. They determined that although decompression and fusion has a slight advantage in terms of clinical effectiveness, MIS decompression alone is significantly more cost-effective and provides for potential cost savings and better service delivery. Similarly, Parker et al 50 found that with MIS-TLIF, patients were discharged home sooner and returned to work faster than did patients treated with open TLIF, thereby reducing costs. The authors also stressed the importance of the large role played by indirect costs in examining total cost.
It is generally accepted that total joint arthroplasty (TJA) is cost effective and restores health-related quality of life; thus, it may serve as a benchmark for clinical outcome expectations. Moreover, the results of lumbar spine surgery are variable and do not share the widespread acceptance afforded TJA. Several authors have investigated whether lumbar spinal fusion can yield outcomes comparable to TJA in age-matched populations. 51, 52 According to these studies, patients treated with lumbar decompression and fusion can expect their health-related quality of life to return to that of age-matched population norms with gains in minimal clinically important difference and substantial clinical benefit similar to that seen in patients following TJA.
Summary
Surgical treatment for DS continues to evolve. From the perspective of the senior author (F.J.E.), laminectomy alone is ideal if the DS is stiff. Laminectomy and posterior instrumented spinal fusion is the current standard of care and is the most commonly performed surgical procedure for the management of DS. TLIF and PLIF are best in cases in which extra stability is needed, more bone surface is needed for fusion, the goal is to improve lordosis, or back pain is worse than leg pain. ALIF with percutaneous screw fixation provides the same type of anterior support, but the ability to perform ALIF depends on the experience and availability of the access surgeon. Lateral transpsoas interbody fusion with percutaneous screw fixation is appropriate provided the patient understands the risk of new groin and thigh symptoms.
Each of these techniques has a learning curve, and comparative data are now available for each technique. When deciding on the appropriate treatment, the surgeon should always consider his or her familiarity with the techniques, understand the potential risks and benefits, weigh the total expense of implants and surgical time, and consider patient length of stay and time away from work.
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